These data indicate that induced NOX4 expression restores suppressed CB-ECFC pro-angiogenic response in experimental diabetes, highlighting this major ROS source as a potential target to protect or enhance CB-ECFC function in this context. The gene discussed is NOX4; the disease is diabetes mellitus.